SCIENTISTS all over the world are racing to develop the perfect vaccine to fight the coronavirus that has threatened mankind for four months now.
Centuries ago, the race to discover a vaccine for any kind of virus was for a noble cause. Unfortunately, we cannot say the same narrative today. There are those who want to discover the panacea for the pandemic mainly for profit. Testing kits are getting to be expensive as the demand for rapid testing is becoming imperative.
Dr. Minguita Padilla, Project Ark Medical team leader, warns and calls for a stop on profiteering and “‘papogi’ points by some sectors, public or private.” Motives and intentions will eventually come out for nothing is concealed that will not be revealed. For those who are into developing the vaccine for personal gain, this I have to say... shame on you on behalf of the thousands of lives lost, especially those who got exposed to the virus while caring for the infected.
Recently, the United States and Canada have allegedly accused Russia of vaccine research hacking. This was denied by Russia.
Scientists from 150 countries are racing against time. There are about 89 vaccines being developed worldwide. There are three phases on the development of the vaccine. Some are already in their third phase of clinical trial and would like to ascertain the safety of the vaccine.
According to WebMD, Phase 1 usually lasts one to two years and involves fewer than 100 people. Phase 2 takes at least two years and includes several hundred people. Phase 3 lasts three to four years and involves thousands of people. Clinical trial process stretches to 15 years or more. About a third of vaccines make it from Phase one to final approval. Then the vaccine has to be presented for final approval.
The tricky part is the distribution globally. We hope that the distribution will be at a pace faster than the spread of Covid-19. Distribution process is underway considering the urgent demand for the vaccine worldwide.
U.S. Health and Human Services Secretary Alex Azar confirmed last Wednesday that 100 million doses of a vaccine from Pfizer could come starting December, as the pharmaceutical company closes a vaccine deal with the superpower.